ID

33112

Beskrivning

A Clinical Study to Evaluate the Effect of Naturlose (Tagatose); ODM derived from: https://clinicaltrials.gov/show/NCT00961662

Länk

https://clinicaltrials.gov/show/NCT00961662

Nyckelord

Versioner (1)
  1. 2018-11-28 2018-11-28 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

28 november 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Type 2 Diabetes NCT00961662

Engelsk

Eligibility Type 2 Diabetes NCT00961662

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetics in accordance with who.
Beskrivning

Non-Insulin-Dependent Diabetes Mellitus WHO classification

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C4267671
male and female patients, between 18 and 75 years of age.
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
diabetic patients who are not on medication for the disease. patients may be treated with diet and exercise.
Beskrivning

Diabetic | Pharmaceutical Preparations Absent | Diet therapy | Exercise

Datatyp

boolean

Alias
UMLS CUI [1]
C0241863
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0332197
UMLS CUI [3]
C0012159
UMLS CUI [4]
C0015259
normal blood creatine clearance and normal liver function test results.
Beskrivning

Creatinine clearance Normal | Liver function tests normal

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0812399
UMLS CUI [1,2]
C0205307
UMLS CUI [2]
C0438235
bmi less than or equal to 45 kg/m2
Beskrivning

Body mass index

Datatyp

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with sulfonylurea (e.g., glyburide, glipizide, glimepiride, chlorpropamide, tolazamide, acetohexamide, or tolbutamide), tzds, metformin, acarbose, byetta, insulin, and any antidiabetic medications within the prior 3 months.
Beskrivning

Sulfonylurea | Glyburide | Glipizide | glimepiride | Chlorpropamide | Tolazamide | Acetohexamide | Tolbutamide | Thiazolidinediones | Metformin | Acarbose | Byetta | Insulin | Antidiabetics

Datatyp

boolean

Alias
UMLS CUI [1]
C0038766
UMLS CUI [2]
C0017628
UMLS CUI [3]
C0017642
UMLS CUI [4]
C0061323
UMLS CUI [5]
C0008287
UMLS CUI [6]
C0040372
UMLS CUI [7]
C0000992
UMLS CUI [8]
C0040374
UMLS CUI [9]
C1257987
UMLS CUI [10]
C0025598
UMLS CUI [11]
C0050393
UMLS CUI [12]
C1636686
UMLS CUI [13]
C0021641
UMLS CUI [14]
C0935929
therapy with beta-blockers or thiazide diuretics within the prior 3 months
Beskrivning

Adrenergic beta-1 Receptor Antagonists | Thiazide Diuretics

Datatyp

boolean

Alias
UMLS CUI [1]
C0304516
UMLS CUI [2]
C0012802
pregnancy, breastfeeding, or intention of becoming pregnant or judged to be using inadequate contraceptive measure.
Beskrivning

Pregnancy | Breast Feeding | Pregnancy, Planned | Contraceptive methods Inadequate

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
UMLS CUI [4,1]
C0700589
UMLS CUI [4,2]
C0205412
documented gastrointestinal disease, or taking of medications likely to alter gut motility or absorption.
Beskrivning

Gastrointestinal Disease | Pharmaceutical Preparations Changing Gastrointestinal Motility | Pharmaceutical Preparations Changing Gastrointestinal Absorption

Datatyp

boolean

Alias
UMLS CUI [1]
C0017178
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0392747
UMLS CUI [2,3]
C0017184
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C0392747
UMLS CUI [3,3]
C3714657
receiving any investigational drug within 30 days of the baseline visit.
Beskrivning

Investigational New Drugs

Datatyp

boolean

Alias
UMLS CUI [1]
C0013230
Tillbaka till toppen

Similar models

Eligibility Type 2 Diabetes NCT00961662

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus WHO classification
Item
type 2 diabetics in accordance with who.
boolean
C0011860 (UMLS CUI [1,1])
C4267671 (UMLS CUI [1,2])
Age
Item
male and female patients, between 18 and 75 years of age.
boolean
C0001779 (UMLS CUI [1])
Diabetic | Pharmaceutical Preparations Absent | Diet therapy | Exercise
Item
diabetic patients who are not on medication for the disease. patients may be treated with diet and exercise.
boolean
C0241863 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0012159 (UMLS CUI [3])
C0015259 (UMLS CUI [4])
Creatinine clearance Normal | Liver function tests normal
Item
normal blood creatine clearance and normal liver function test results.
boolean
C0812399 (UMLS CUI [1,1])
C0205307 (UMLS CUI [1,2])
C0438235 (UMLS CUI [2])
Body mass index
Item
bmi less than or equal to 45 kg/m2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Sulfonylurea | Glyburide | Glipizide | glimepiride | Chlorpropamide | Tolazamide | Acetohexamide | Tolbutamide | Thiazolidinediones | Metformin | Acarbose | Byetta | Insulin | Antidiabetics
Item
treatment with sulfonylurea (e.g., glyburide, glipizide, glimepiride, chlorpropamide, tolazamide, acetohexamide, or tolbutamide), tzds, metformin, acarbose, byetta, insulin, and any antidiabetic medications within the prior 3 months.
boolean
C0038766 (UMLS CUI [1])
C0017628 (UMLS CUI [2])
C0017642 (UMLS CUI [3])
C0061323 (UMLS CUI [4])
C0008287 (UMLS CUI [5])
C0040372 (UMLS CUI [6])
C0000992 (UMLS CUI [7])
C0040374 (UMLS CUI [8])
C1257987 (UMLS CUI [9])
C0025598 (UMLS CUI [10])
C0050393 (UMLS CUI [11])
C1636686 (UMLS CUI [12])
C0021641 (UMLS CUI [13])
C0935929 (UMLS CUI [14])
Adrenergic beta-1 Receptor Antagonists | Thiazide Diuretics
Item
therapy with beta-blockers or thiazide diuretics within the prior 3 months
boolean
C0304516 (UMLS CUI [1])
C0012802 (UMLS CUI [2])
Pregnancy | Breast Feeding | Pregnancy, Planned | Contraceptive methods Inadequate
Item
pregnancy, breastfeeding, or intention of becoming pregnant or judged to be using inadequate contraceptive measure.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0700589 (UMLS CUI [4,1])
C0205412 (UMLS CUI [4,2])
Gastrointestinal Disease | Pharmaceutical Preparations Changing Gastrointestinal Motility | Pharmaceutical Preparations Changing Gastrointestinal Absorption
Item
documented gastrointestinal disease, or taking of medications likely to alter gut motility or absorption.
boolean
C0017178 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C0017184 (UMLS CUI [2,3])
C0013227 (UMLS CUI [3,1])
C0392747 (UMLS CUI [3,2])
C3714657 (UMLS CUI [3,3])
Investigational New Drugs
Item
receiving any investigational drug within 30 days of the baseline visit.
boolean
C0013230 (UMLS CUI [1])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial